University Medical Centre Groningen — Groningen, Provincie Groningen

Public research footprint of University Medical Centre Groningen, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Peritoneal Neoplasm Malignant Secondary Carcinomatosis · Behçet's Syndrome (BS) · Immune-mediated Necrotizing Myopathy (IMNM) · Cutaneous Melanoma, Stage II

Recently updated registry entries

NCT06371417 — Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) (Recruiting)
NCT06723106 — Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) (Enrolling By Invitation)
NCT06162221 — Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Medical Centre Groningen?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.